Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
BIIB
#417
Biogen Inc. - Common Stock
228.9
0
USD
0.00%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-0.22%
Monthly Change
+5.63%
6 month change
+27.62%
Year Change
+58.15%
Previous Close
229.4
1
Open
230.3
4
Low
226.7
1
High
231.0
4
Markets
US Stock Market
Healthcare
Drug Manufacturers—General
BIIB
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
152.34 M
146.96 M
144.49 M
145.36 M
146.37 M
146.76 M
147.75 M
Valuation ratios
Enterprise value
44.16 B
42.26 B
43.1 B
45.24 B
27.01 B
29.88 B
31.47 B
Price to earnings ratio
9.87
23.07
13.06
33.59
13.68
20.02
38.52
Price to sales ratio
2.94
3.27
3.91
3.96
2.31
2.62
—
Price to cash flow ratio
9.34
9.86
28.75
25.19
7.76
11.74
10.55
Price to book ratio
3.69
3.29
2.97
2.63
-9.82
-11.28
—
Enterprise value to EBITDA ratio
8.82
12.7
10.49
25.25
10.47
12.79
—
Profitability ratios
Return on assets %
0.16
0.07
0.12
0.04
0.06
0.04
0
Return on equity %
0.37
0.14
0.23
0.08
0.1
0.07
0.01
Return on invested capital %
65.61
52.93
167.59
115.26
97.87
20.1
2.6
Gross margin %
86.57
80.79
77.61
74.24
76.12
75.69
71.6
Operating margin %
33.84
25.87
35.31
13.18
19.7
15.74
9.5
EBITDA margin %
37.24
30.31
40.4
18.22
26.66
23.62
18.46
Net margin %
29.76
14.17
29.95
11.81
16.87
13.07
3.56
Liquidity ratios
Quick ratio
1.55
1.51
2.58
1.26
0.9
2.03
1.26
Current ratio
1.84
1.83
2.99
2
1.35
2.68
1.87
Inventory turnover
1.93
1.74
1.69
1.31
0.93
1.11
0.33
Asset turnover
0.52
0.45
0.42
0.38
0.35
0.34
0.09
Solvency ratios
Debt to assets ratio
0.3
0.36
0.27
0.26
0.22
0.21
—
Debt to equity ratio
0.7
0.79
0.49
0.47
-2.47
-2.74
—
Long term debt to total assets ratio
0.3
0.26
0.26
0.26
0.22
0.21
0.23
Long term debt to total equity ratio
0.69
0.58
0.47
0.47
-2.47
-2.74
0.38
Per share metrics
Operating cash flow per share
26.22
24.33
9.48
10.63
19.71
14.99
20.55
EBIT per share
28.21
18.99
24.6
8.91
13.06
10.58
6.84
EBITDA per share
31.04
22.25
28.15
12.3
17.68
15.88
13.46
Total debt per share
46.5
57.26
44.98
47.65
43.15
42.74
—
Cash per share
11.82
28.22
35.02
7.06
12.64
21.47
5.07
Net current asset value per share
42.7
52.52
67.06
47.11
51.11
61.01
49.16
Tangible book value per share
66.34
72.84
91.77
101.64
-128.27
-122.13
-9.45
Working capital per share
19.5
23.79
44.65
23.52
13.21
38.24
22.8
Book value per share
66.34
72.84
91.77
101.64
-17.44
-15.61
128.56
News
Why A Biotech M&A Wave May Hit This Winter
Biogen’s Quarterly Earnings Preview: What You Need to Know
Stocks Settle Lower as Crude Prices Jump and Chipmakers Fall
Stocks Pressured by Rising Crude Prices and Chipmaker Weakness
Stocks Mixed Ahead of Q3 Earnings Season
JP Morgan Upgrades Biogen to Overweight, Raises Price Target to $300
UBS Maintains Buy on Biogen, Raises Price Target to $270
RBC Capital Maintains Outperform on Biogen, Lowers Price Target to $256
Stocks Fall and Bond Yields Rise on Inflation Worries
Stocks Pressured by Rising Bond Yields
Stock Picks From Seeking Alpha's September 2026 New Analysts
Will Biogen (BIIB) Beat Estimates Again in Its Next Earnings Report?